Product name:Cabazitaxel
CAS:183133-96-2
Molecular formula:C45H57NO14
Molecular weight:835.93
Product description:Cabazitaxel is a semi-synthetic derivative of a natural taxoid. It was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
For more information OR other specifications of the products, please contact us.
This form is unable to receive your inquiry from aol, hotmail, gmail or others but company email address.For more information OR other products. Please contact us by Email, Tel, Fax or Send online enquiry. We will reply you as soon as possible.
1. Email: sales@pharmaceutiucal-materials.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6516 2351